SUPRIYA LIFESCIENCE
Back to Cashflow Statement
|
SUPRIYA LIFESCIENCE Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹186 Cr | ₹165 Cr | ₹113 Cr | ₹64 Cr | ₹49 Cr |
What is the latest Cash Flow from Operating Activities ratio of SUPRIYA LIFESCIENCE ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹186 Cr |
| Mar2025 | ₹165 Cr |
| Mar2024 | ₹113 Cr |
| Mar2023 | ₹64 Cr |
| Mar2022 | ₹49 Cr |
How is Cash Flow from Operating Activities of SUPRIYA LIFESCIENCE Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹186 Cr | 12.81 | |
| Mar2025 | ₹165 Cr | 45.34 | |
| Mar2024 | ₹113 Cr | 78.14 | |
| Mar2023 | ₹64 Cr | 30.34 | |
| Mar2022 | ₹49 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹5,602.0 Cr | -17% | -21.8% | 12.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | -17% |
-21.8% |
12.1% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses